HARP - Harpoon Therapeutics GAAP EPS of -$0.35 beats by $0.20 revenue of $13.6M beats by $7.25M
- Harpoon Therapeutics press release ( NASDAQ: HARP ): Q3 GAAP EPS of -$0.35 beats by $0.20 .
- Revenue of $13.6M (+203.6% Y/Y) beats by $7.25M .
- Harpoon ended the third quarter of 2022 with $66.1M in cash, cash equivalents and marketable securities, compared to $136.6M as of December 31, 2021. Current cash is expected to fund operations through the end of 2023.
For further details see:
Harpoon Therapeutics GAAP EPS of -$0.35 beats by $0.20, revenue of $13.6M beats by $7.25M